| |
Group A (n=82) |
Group B (n=82) |
P value |
| Age (y) |
53 ± 10 |
55 ± 11 |
0.51 |
| |
(range: 34-83) |
(range: 30-80) |
|
| Female patients (n, %) |
35 (-42.7%) |
31 (37.8%) |
0.63 |
| BMI (kg/m2) |
22.15 ± 2.0 (range: 19.8-27.5) |
22.74 ± 2.2 (range: 19.8-28.4) |
0.1 |
| HR (bpm) |
62 ± 5 |
60 ± 4 |
0.08 |
| |
(range: 45-65) |
(range: 46-65) |
|
| Hypertension |
32 (-39%) |
36 (43.9%) |
0.64 |
| Hyperlipidaemia |
48 (-58.5%) |
44 (53.7%) |
0.63 |
| Diabetes mellitu |
23 (-28%) |
18 (22.0%) |
0.47 |
| Family history of CAD |
8 (9.8%) |
10 (12.2%) |
0.8 |
| Smoking |
28 (-34.1%) |
25 (30.5%) |
0.74 |
| Scan length (cm) |
463.39 ± 36.06 |
464.12 ± 36.35 |
0.89 |
| |
(range: 416-744) |
(range: 414-538) |
|
| Scan time (ms) |
679.88 ± 48.41 |
887.22 ± 67.24 |
0.001 |
| |
(range: 575-785) |
(range: 735-1024) |
|
| DLP(mGy.cm) |
197.05 ± 16.04 |
416.45 ± 22.36 |
<.001 |
Abbreviations: BMI=body mass index, HR=heart rate, bpm=beats per minute, CAD=coronary artery disease, DLP= dose-length product. |